In patients who cannot tolerate statins due to side effects, bempedoic acid leads to a lower risk of major cardiovascular events. That is the conclusion of a large international trial that was recently published in The New England Journal of Medicine (2023; online 13 april).
For both primary and secondary prevention…
The entire content of this article is only accessible to subscribers.
Read 3 articles FREE
Make an account. Free and without obligation.
I want 3x free
Always access to all NTvG publications?
Subscribe today!
Take the introductory subscription
€ 32.95 for 12 weeks!
I want to meet
Do you already have a subscription? login
2023-05-18 04:00:00
#Bempedoic #acid #alternative #statin